#EBW24 previews: Speakers for panel session ‘The road towards ISO 20387 accreditation’

We are delighted to confirm the speakers for panel session ‘The road towards ISO 20387 accreditation’: Andrea Martina Terracciano and Dr. Sabine Bavamian. The session takes place on Wednesday 15 May 2024 as part of the EBW24 programme.

Andrea Martina Terracciano

Andrea Martina Terracciano moved in England in 2017 after graduating with a BSc (Hons) in Biomedical Sciences from the University of Pavia, in Italy. She holds registration as Biomedical Scientist both in the United Kingdom and in Italy.

 She has worked in different sectors focusing on quality assurance and product and process control. After permanently moving to the medical field in 2021, her first role was managing and maintaining UKAS accreditation for ISO 15189:2012 Medical Laboratories and ISO 22870:2006 Point of Care Testing for two different laboratories.

In 2023 she was appointed as Cancer Biobank Quality Manager at the King’s Health Partners Cancer Biobank at Guy’s Cancer Centre in 2023 and has been working on maintaining Human Tissue Authority license and obtaining accreditation for ISO 20387:2018 Biotechnology – Biobanking – General requirements for biobanking.

Sabine Bavamian

Sabine Bavamian is a biologist by training. She gained her scientific background from more than 10 years in clinical and academic research. She graduated with a PhD in biology in the field of diabetes from the University of Geneva in Switzerland before being appointed as a Postdoctoral fellow at the Broad Institute of Harvard and the MIT in Cambridge (USA). There, she was involved in both clinical and academic research settings on projects related to psychiatric disorders. Back to Switzerland, she transitioned to clinical research by earning a master’s degree in “Management of Clinical Trials”. Since 2016, she joined Swiss Biobanking Platform, the reference research infrastructure for human and non-human biobanks funded by the Swiss National Science Foundation where she is now appointed as Chief Scientific Officer.